Low-risk prostate cancer and low testosterone: what are the acceptable alternatives?
Soloway
Mark
M
Department of Urology, University of Miami, Miller School of Medicine, Dominion Towers, 1400 NW 10th Avenue, Suite 506, Miami, FL 33136, USA. msoloway@med.miami.edu
D000728:Androgens / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000628:therapy*; D012307:Risk Factors; D013739:Testosterone / Q000008:administration & dosage
D000728:Androgens; D013739:Testosterone